Anika Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $210.8M | $110.7M |
| FY2016 | — | $222.8M | $104.3M |
| FY2017 | — | $263.5M | $133.3M |
| FY2018 | — | $263.6M | $89.0M |
| FY2019 | — | $288.4M | $157.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $210.8M | $110.7M |
| FY2016 | — | $222.8M | $104.3M |
| FY2017 | — | $263.5M | $133.3M |
| FY2018 | — | $263.6M | $89.0M |
| FY2019 | — | $288.4M | $157.5M |